package org.qsari.effectopedia.data.generated;
import org.qsari.effectopedia.core.objects.DescriptionSection;
import org.qsari.effectopedia.core.objects.DescriptionSection.ContentFormat;
import org.qsari.effectopedia.core.objects.DescriptionSection_Structured;
import org.qsari.effectopedia.core.objects.Effect_AdverseOutcome;
import org.qsari.effectopedia.core.objects.Effect_DownstreamEffect;
import org.qsari.effectopedia.core.objects.Effect_Endpoint;
import org.qsari.effectopedia.core.objects.Effect_MolecularInitiatingEvent;
import org.qsari.effectopedia.core.objects.Initiator_ChemicalStructure;
import org.qsari.effectopedia.core.objects.Link;
import org.qsari.effectopedia.core.objects.Link_ChemStructToMIE;
import org.qsari.effectopedia.core.objects.Link_EffectToEffect;
import org.qsari.effectopedia.core.objects.Method_Investigation;
import org.qsari.effectopedia.core.objects.Method_Study;
import org.qsari.effectopedia.core.objects.Pathway;
import org.qsari.effectopedia.core.objects.Reference;
import org.qsari.effectopedia.core.objects.SubstanceData;
import org.qsari.effectopedia.core.objects.TestResponseMapping;
import org.qsari.effectopedia.core.objects.Test_InVitro;
import org.qsari.effectopedia.core.objects.Test_InVivo;
import org.qsari.effectopedia.core.objects.Test_ExVivo;
import org.qsari.effectopedia.data.DataSource;
import org.qsari.effectopedia.data.objects.ObjectProperties;
import org.qsari.effectopedia.data.objects.ObjectPropertyMultivalued_Documented;
import org.qsari.effectopedia.defaults.DefaultDataTemplates;
import org.qsari.effectopedia.defaults.DefaultEffectopediaObjects;
import org.qsari.effectopedia.system.User;
import org.qsari.effectopedia.data.RevisionBasedDS;
import org.qsari.effectopedia.core.objects.Link.LinkType;
import org.qsari.effectopedia.base.ids.ReferenceIDW;
import org.qsari.effectopedia.core.object.elemets.EssetialityDescription;

public class AOP1	extends SourceGeneratedPathway {

public AOP1(DataSource dataSource) {
super("PPARα activation leading to impaired fertility in adult male rodents ","",dataSource,"D://Java//org.qsari.effectopedia//test//PPARα activation leading to impaired fertility in adult male rodents ");
}
public AOP1(DataSource dataSource, boolean autoSave) {
super("PPARα activation leading to impaired fertility in adult male rodents ","",dataSource,"D://Java//org.qsari.effectopedia//test//PPARα activation leading to impaired fertility in adult male rodents ",autoSave);
}
protected Effect_MolecularInitiatingEvent effect_molecularinitiatingevent1;//7771
protected Effect_AdverseOutcome effect_adverseoutcome2;//7779
protected Effect_DownstreamEffect effect_downstreameffect3;//7788
protected Effect_DownstreamEffect effect_downstreameffect4;//7795
protected Link_EffectToEffect link_effecttoeffect5;//7802
protected Effect_DownstreamEffect effect_downstreameffect6;//7819
protected Effect_DownstreamEffect effect_downstreameffect7;//7826
protected Link_EffectToEffect link_effecttoeffect8;//7833
protected Effect_DownstreamEffect effect_downstreameffect9;//7848
protected Link_EffectToEffect link_effecttoeffect10;//7855
protected Effect_DownstreamEffect effect_downstreameffect11;//7870
protected Link_EffectToEffect link_effecttoeffect12;//7877
protected Link_EffectToEffect link_effecttoeffect13;//7892
protected Link_EffectToEffect link_effecttoeffect14;//7907
@Override
public void generateContent()
{genreateRevision1();
storeRevision();
if (dataSource instanceof RevisionBasedDS)
((RevisionBasedDS) dataSource).setLocation(pathway);
}
public void genreateRevision1() {

effect_molecularinitiatingevent1 = new Effect_MolecularInitiatingEvent(pathway, dataSource);
effect_molecularinitiatingevent1.setTitle("Activation, PPARα");
effect_molecularinitiatingevent1.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "molecular");
effect_molecularinitiatingevent1.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Rattus norvegicus, Mus musculus, Homo sapiens");
effect_molecularinitiatingevent1.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_molecularinitiatingevent1.getDescriptionIDs().set(new DescriptionSection(effect_molecularinitiatingevent1,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><b>Biological state</b>\n\n</p><p>The Peroxisome Proliferator Activated receptor α (PPARα) belongs to the  <a href=\"/wiki/index.php/Peroxisome_Proliferator_Activated_receptors_(PPARs;_NR1C)\" title=\"Peroxisome Proliferator Activated receptors (PPARs; NR1C)\">Peroxisome Proliferator Activated receptors (PPARs; NR1C)</a> steroid/thyroid/retinoid receptor superfamily of transcription factors.\n\n</p><p><b>Biological compartments</b>\n\n</p><p>PPARα is expressed in high levels in tissues that perform significant catabolism of fatty acids (FAs), such as brown adipose tissue, liver, heart, kidney, and intestine (Michalik et al. 2006). The receptor is present also in skeletal muscle, intestine, pancreas, lung, placenta and testes (Mukherjee et al. 1997), (Schultz et al. 1999). \n\n</p><p><b>General role in biology</b>\n\n</p><p>PPARs are activated by fatty acids and their derivatives; they are sensors of dietary lipids and are involved in lipid and carbohydrate metabolism, immune response and peroxisome proliferation (Wahli and Desvergne 1999), (Evans, Barish, &amp; Wang, 2004). PAPRα is a also a target of hypothalamic hormone signalling and was found to play a role in embryonic development (Yessoufou and Wahli 2010).\n\n</p><p>Fibrates, activators of PPARα, are commonly used to treat hypertriglyceridemia and other dyslipidemic states as they have been shown to decrease circulating lipid levels (Lefebvre et al. 2006).\n\n</p></p></div><div class='references'><h3>References</h3><p><p>Bhattacharya, Nandini, Jannette M Dufour, My-Nuong Vo, Janice Okita, Richard Okita, and Kwan Hee Kim. 2005. “Differential Effects of Phthalates on the Testis and the Liver.” Biology of Reproduction 72 (3) (March): 745–54. doi:10.1095/biolreprod.104.031583.\n\n</p><p>Bility, Moses T, Jerry T Thompson, Richard H McKee, Raymond M David, John H Butala, John P Vanden Heuvel, and Jeffrey M Peters. 2004. “Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters.” Toxicological Sciences : An Official Journal of the Society of Toxicology 82 (1) (November): 170–82. doi:10.1093/toxsci/kfh253.\n\n</p><p>Dufour, Jannette M, My-Nuong Vo, Nandini Bhattacharya, Janice Okita, Richard Okita, and Kwan Hee Kim. 2003. “Peroxisome Proliferators Disrupt Retinoic Acid Receptor Alpha Signaling in the Testis.” Biology of Reproduction 68 (4) (April): 1215–24. doi:10.1095/biolreprod.102.010488.\n\n</p><p>Feige, Jérôme N, Laurent Gelman, Daniel Rossi, Vincent Zoete, Raphaël Métivier, Cicerone Tudor, Silvia I Anghel, et al. 2007. “The Endocrine Disruptor Monoethyl-Hexyl-Phthalate Is a Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator That Promotes Adipogenesis.” The Journal of Biological Chemistry 282 (26) (June 29): 19152–66. doi:10.1074/jbc.M702724200.\n\n</p><p>Hurst, Christopher H, and David J Waxman. 2003. “Activation of PPARalpha and PPARgamma by Environmental Phthalate Monoesters.” Toxicological Sciences : An Official Journal of the Society of Toxicology 74 (2) (August): 297–308. doi:10.1093/toxsci/kfg145.\n\n</p><p>Kaya, Taner, Scott C Mohr, David J Waxman, and Sandor Vajda. 2006. “Computational Screening of Phthalate Monoesters for Binding to PPARgamma.” Chemical Research in Toxicology 19 (8) (August): 999–1009. doi:10.1021/tx050301s.\n\n</p><p>Lampen, Alfonso, Susan Zimnik, and Heinz Nau. 2003. “Teratogenic Phthalate Esters and Metabolites Activate the Nuclear Receptors PPARs and Induce Differentiation of F9 Cells.” Toxicology and Applied Pharmacology 188 (1) (April): 14–23. doi:10.1016/S0041-008X(03)00014-0.\n\n</p><p>Lapinskas, Paula J., Sherri Brown, Lisa M. Leesnitzer, Steven Blanchard, Cyndi Swanson, Russell C. Cattley, and J. Christopher Corton. 2005. “Role of PPARα in Mediating the Effects of Phthalates and Metabolites in the Liver.” Toxicology 207 (1): 149–163.\n\n</p><p>Le Maire, Albane, Marina Grimaldi, Dominique Roecklin, Sonia Dagnino, Valérie Vivat-Hannah, Patrick Balaguer, and William Bourguet. 2009. “Activation of RXR-PPAR Heterodimers by Organotin Environmental Endocrine Disruptors.” EMBO Reports 10 (4) (April): 367–73. doi:10.1038/embor.2009.8.\n\n</p><p>LeBlanc, GA, DO Norris, and W Kloas. 2011. “Detailed Review Paper State of the Science on Novel In Vitro and In Vivo Screening and Testing Methods and Endpoints for Evaluating Endocrine Disruptors” (178).\n\n</p><p>Lefebvre, Philippe, Giulia Chinetti, Jean-Charles Fruchart, and Bart Staels. 2006. “Sorting out the Roles of PPAR Alpha in Energy Metabolism and Vascular Homeostasis.” The Journal of Clinical Investigation 116 (3) (March): 571–80. doi:10.1172/JCI27989.\n\n</p><p>Maloney, Erin K., and David J. Waxman. 1999. “Trans-Activation of PPARα and PPARγ by Structurally Diverse Environmental Chemicals.” Toxicology and Applied Pharmacology 161 (2): 209–218.\n\n</p><p>Michalik, Liliane, Johan Auwerx, Joel P Berger, V Krishna Chatterjee, Christopher K Glass, Frank J Gonzalez, Paul A Grimaldi, et al. 2006. “International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors.” Pharmacological Reviews 58 (4) (December): 726–41. doi:10.1124/pr.58.4.5.\n\n</p><p>Mukherjee, R, L Jow, G E Croston, and J R Paterniti. 1997. “Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-Activated Receptor (PPAR) Isoforms PPARgamma2 versus PPARgamma1 and Activation with Retinoid X Receptor Agonists and Antagonists.” The Journal of Biological Chemistry 272 (12) (March 21): 8071–6.\n\n</p><p>Schultz, R, W Yan, J Toppari, A Völkl, J A Gustafsson, and M Pelto-Huikko. 1999. “Expression of Peroxisome Proliferator-Activated Receptor Alpha Messenger Ribonucleic Acid and Protein in Human and Rat Testis.” Endocrinology 140 (7) (July): 2968–75. doi:10.1210/endo.140.7.6858.\n\n</p><p>Staels, B., J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J.-C. Fruchart. 1998. “Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism.” Circulation 98 (19) (November 10): 2088–2093. doi:10.1161/01.CIR.98.19.2088.\n\n</p><p>ToxCastTM Data. “ToxCastTM Data.” US Environmental Protection Agency. <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://www.epa.gov/ncct/toxcast/data.html\">http://www.epa.gov/ncct/toxcast/data.html</a>\n\n</p><p>Vanden Heuvel, John P, Jerry T Thompson, Steven R Frame, and Peter J Gillies. 2006. “Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-Alpha, -Beta, and -Gamma, Liver X Receptor-Beta, and Retinoid X Rec.” Toxicological Sciences : An Official Journal of the Society of Toxicology 92 (2) (August): 476–89. doi:10.1093/toxsci/kfl014.\n\n</p><p>Venkata, Nagaraj Gopisetty, Jodie a Robinson, Peter J Cabot, Barbara Davis, Greg R Monteith, and Sarah J Roberts-Thomson. 2006. “Mono(2-Ethylhexyl)phthalate and Mono-N-Butyl Phthalate Activation of Peroxisome Proliferator Activated-Receptors Alpha and Gamma in Breast.” Toxicology Letters 163 (3) (June 1): 224–34. doi:10.1016/j.toxlet.2005.11.001.\n\n</p><p>Viswakarma, Navin, Yuzhi Jia, Liang Bai, Aurore Vluggens, Jayme Borensztajn, Jianming Xu, and Janardan K Reddy. 2010. “Coactivators in PPAR-Regulated Gene Expression.” PPAR Research 2010 (January). doi:10.1155/2010/250126.\n\n</p><p>Wahli, Walter, and B Desvergne. 1999. “Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism.” Endocrine Reviews 20 (5) (October): 649–88.\n\nWu, Bin, Jie Gao, and Ming-wei Wang. 2005. “Development of a Complex Scintillation Proximity Assay for High-Throughput Screening of PPARgamma Modulators.” Acta Pharmacologica Sinica 26 (3) (March): 339–44. doi:10.1111/j.1745-7254.2005.00040.x.\n\n</p><p>Xu, Chuan, Ji-An Chen, Zhiqun Qiu, Qing Zhao, Jiaohua Luo, Lan Yang, Hui Zeng, et al. 2010. “Ovotoxicity and PPAR-Mediated Aromatase Downregulation in Female Sprague-Dawley Rats Following Combined Oral Exposure to Benzo[a]pyrene and Di-(2-Ethylhexyl) Phthalate.” Toxicology Letters 199 (3) (December 15): 323–32. doi:10.1016/j.toxlet.2010.09.015.\n\n</p><p>Yessoufou, a, and W Wahli. 2010. “Multifaceted Roles of Peroxisome Proliferator-Activated Receptors (PPARs) at the Cellular and Whole Organism Levels.” Swiss Medical Weekly 140 (September) (January): w13071. doi:10.4414/smw.2010.13071.\n\n</p><p>Yu, Songtao, and Janardan K Reddy. 2007. “Transcription Coactivators for Peroxisome Proliferator-Activated Receptors.” Biochimica et Biophysica Acta 1771 (8) (August): 936–51. doi:10.1016/j.bbalip.2007.01.008.\n\n</p></p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_MolecularInitiatingEvent> effect_molecularinitiatingevent1_weigth1= new ReferenceIDW<Effect_MolecularInitiatingEvent>(effect_molecularinitiatingevent1, dataSource, Effect_MolecularInitiatingEvent.class,1.0);
effect_molecularinitiatingevent1.getDescriptionIDs().set(new DescriptionSection_Structured(effect_molecularinitiatingevent1,dataSource,"(Key) Event Essentiality","", effect_molecularinitiatingevent1_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_adverseoutcome2 = new Effect_AdverseOutcome(pathway, dataSource);
effect_adverseoutcome2.setTitle("impaired, Fertility");
effect_adverseoutcome2.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "individual");
effect_adverseoutcome2.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Rattus norvegicus, Mus musculus, Homo sapiens");
effect_adverseoutcome2.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_adverseoutcome2.getDescriptionIDs().set(new DescriptionSection(effect_adverseoutcome2,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><strong>Biological state</strong></p>\n\n<p>capability to produce offspring</p>\n\n<p><strong>Biological compartments</strong></p>\n\n<p>System</p>\n\n<p><strong>General role in biology</strong></p>\n\n<p>Fertility is the capacity to conceive or induce conception. Impairment of fertility represents disorders of male or female reproductive functions or capacity.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_AdverseOutcome> effect_adverseoutcome2_weigth1= new ReferenceIDW<Effect_AdverseOutcome>(effect_adverseoutcome2, dataSource, Effect_AdverseOutcome.class,0.0);
effect_adverseoutcome2.getDescriptionIDs().set(new DescriptionSection_Structured(effect_adverseoutcome2,dataSource,"(Key) Event Essentiality","", effect_adverseoutcome2_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect3 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect3.setTitle("Increase proliferation, Leydig cell ");
effect_downstreameffect3.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "cellular");
effect_downstreameffect3.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Rattus norvegicus");
effect_downstreameffect3.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect3.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect3,dataSource,"Description","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect3_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect3, dataSource, Effect_DownstreamEffect.class,2.0);
effect_downstreameffect3.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect3,dataSource,"(Key) Event Essentiality","", effect_downstreameffect3_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect4 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect4.setTitle("Hyperplasia, Leydig cell");
effect_downstreameffect4.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "organ");
effect_downstreameffect4.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Rattus norvegicus");
effect_downstreameffect4.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect4.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect4,dataSource,"Description","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect4_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect4, dataSource, Effect_DownstreamEffect.class,2.0);
effect_downstreameffect4.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect4,dataSource,"(Key) Event Essentiality","", effect_downstreameffect4_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect6 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect6.setTitle("Reduction, Testosterone synthesis in Leydig cells");
effect_downstreameffect6.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "cellular");
effect_downstreameffect6.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Rattus norvegicus, Homo sapiens, Mus sp.");
effect_downstreameffect6.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect6.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect6,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><b>Biological state</b>\n\n</p><p>Testosterone is a steroid hormone from the androgen group and is found in humans and other vertebrates. \n\n</p><p><b>Biological compartments</b>\n\n</p><p>In humans and other mammals, testosterone is secreted primarily by the testicles of males and, to a lesser extent, the ovaries of females and other steroidogenic tissues (e.g., brain, adipose). It either acts locally /or is transported to other tissues via blood circulation. Testosterone synthesis takes place within the mitochondria of Leydig cells, the testosterone-producing cells of the testis. It is produced upon stimulation of these cells by Luteinizing hormone (LH) that is secreted in pulses into the peripheral circulation by the pituitary gland in response to Gonadotropin-releasing hormone (GnRH) from the hypothalamus. Testosterone and its aromatized product, estradiol, feed back to the hypothalamus and pituitary gland to suppress transiently LH and thus testosterone production. In response to reduced testosterone levels, GnRH and LH are produced. This negative feedback cycle results in pulsatile secretion of LH followed by pulsatile production of testosterone (Ellis, Desjardins, and Fraser 1983), (Chandrashekar and Bartke 1998).\n\n</p><p><b>General role in biology</b>\n\n</p><p>Testosterone is the principal male sex hormone and an anabolic steroid. Male sexual differentiation depends on testosterone (T), dihydrotestosterone (DHT), and the expression of androgen receptors by target cells (Manson and Carr 2003). During the development secretion of androgens by Leydig cells is essential for masculinization of the foetus (Nef 2000). \n\nThe foetal Leydig cells develop in utero. These cells become competent to produce testosterone in rat  by gestational day (GD) 15.5, with increasing production thereafter. Peak steroidogenic activity is reached just prior to birth, on GD19 (Chen, Ge, and Zirkin 2009). Testosterone secreted by foetal Leydig cells is required for the differentiation of the male urogenital system late in gestation (Huhtaniemi and Pelliniemi 1992). Foetal Leydig cells also play a role in the scrotal descent of the testis through their synthesis of insulin-like growth factor 3 (Insl3), for review see (Nef 2000).\n\n</p><p>In humans, the first morphological sign of testicular differentiation is the formation of testicular cords, which can be seen between 6 and 7 weeks of gestation. Steroid-secreting Leydig cells can be seen in the testis at 8 weeks of gestation. At this period, the concentration of androgens in the testicular tissue and blood starts to rise, peaking at 14-16 weeks of gestation. This increase comes with an increase in the number of Leydig cells for review see (Rouiller-Fabre et al. 2009).\n\n</p><p>Adult Leydig cells, which are distinct from the foetal Leydig cells, form during puberty and supply the testosterone required for the onset of spermatogenesis, among other functions. Distinct stages of adult Leydig cell development have been identified and characterized. The stem Leydig cells are undifferentiated cells that are capable of indefinite self-renewal but also of differentiation to steroidogenic cells. These cells give rise to progenitor Leydig cells,  which proliferate, continue to differentiate, and give rise to the immature Leydig cells. Immature Leydig cells synthesize high levels of testosterone metabolites and develop into  terminally differentiated adult Leydig cells, which  produce high levels of testosterone. With aging, both serum and testicular testosterone concentrations progressively decline, for review see (Nef 2000).\n\n</p><p>Androgens play a crucial role in the development and maintenance of male reproductive and sexual functions.\n\nLow levels of circulating androgens can cause disturbances in male sexual development, resulting in congenital\n\nabnormalities of the male reproductive tract. Later in life, this may cause reduced fertility, sexual dysfunction,\n\ndecreased muscle formation and bone mineralisation, disturbances of fat metabolism, and cognitive\n\ndysfunction. Testosterone levels decrease as a process of ageing: signs and symptoms caused by this decline\n\ncan be considered a normal part of ageing.\n\n</p></p></div><div class='references'><h3>References</h3><p><p>Chandrashekar, V, and A Bartke. 1998. “The Role of Growth Hormone in the Control of Gonadotropin Secretion in Adult Male Rats.” Endocrinology 139 (3) (March): 1067–74. doi:10.1210/endo.139.3.5816.\n\n</p><p>Ellis, G B, C Desjardins, and H M Fraser. 1983. “Control of Pulsatile LH Release in Male Rats.” Neuroendocrinology 37 (3) (September): 177–83.\n\nHuhtaniemi, I, and L J Pelliniemi. 1992. “Fetal Leydig Cells: Cellular Origin, Morphology, Life Span, and Special Functional Features.” Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 201 (2) (November): 125–40.\n\n</p><p>Manson, Jeanne M, and Michael C Carr. 2003. “Molecular Epidemiology of Hypospadias: Review of Genetic and Environmental Risk Factors.” Birth Defects Research. Part A, Clinical and Molecular Teratology 67 (10) (October): 825–36. doi:10.1002/bdra.10084.\n\n</p><p>Nef, S. 2000. “Hormones in Male Sexual Development.” Genes &amp; Development 14 (24) (December 15): 3075–3086. doi:10.1101/gad.843800.\n\n</p><p>Rouiller-Fabre, Virginie, Vincent Muczynski, Romain Lambrot, Charlotte Lécureuil, Hervé Coffigny, Catherine Pairault, Delphine Moison, et al. 2009. “Ontogenesis of Testicular Function in Humans.” Folia Histochemica et Cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 47 (5) (January): S19–24. doi:10.2478/v10042-009-0065-4.\n\n</p></p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect6_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect6, dataSource, Effect_DownstreamEffect.class,2.0);
effect_downstreameffect6.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect6,dataSource,"(Key) Event Essentiality","", effect_downstreameffect6_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect7 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect7.setTitle("Reduction, testosterone level");
effect_downstreameffect7.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "tissue");
effect_downstreameffect7.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Homo sapiens, Rattus norvegicus, Mus musculus");
effect_downstreameffect7.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect7.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect7,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><strong>Biological state</strong></p>\n\n<p>Testosterone (T) is a steroid hormone from the androgen group. T serves as a substrate for two metabolic pathways that produce antagonistic sex steroids.</p>\n\n<p><strong>Biological compartments</strong></p>\n\n<p>Testosterone is synthesized by the gonads and other steroidogenic tissues (e.g., brain, adipose), acts locally and/or is transported to other tissues via blood circulation. Leydig cells are the testosterone-producing cells of the testis.</p>\n\n<p><strong>General role in biology</strong></p>\n\n<p>Androgens, the main male sex steroids, are the critical factors responsible for the development of the male phenotype during embryogenesis and for the achievement of sexual maturation at puberty. In adulthood, androgens remain essential for the maintenance of male reproductive function and behaviour. Apart from their effects on reproduction, androgens affect a wide variety of non-reproductive tissues such as skin, bone, muscle, and brain (Heemers, Verhoeven, &amp; Swinnen, 2006). Androgens, principally T and 5&alpha;-dihydrotestosterone (DHT), exert most of their effects by interacting with a specific receptor, the androgen receptor (AR), for review see (Murashima, Kishigami, Thomson, &amp; Yamada, 2015). On the one hand, testosterone can be reduced by 5&alpha;-reductase to produce 5&alpha; dihydrotestosterone (DHT). On the other hand, testosterone can be aromatized to generate estrogens. Testosterone effects can also be classified by the age of usual occurrence, postnatal effects in both males and females are mostly dependent on the levels and duration of circulating free testosterone.</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Heemers, H. V, Verhoeven, G., &amp; Swinnen, J. V. (2006). Androgen activation of the sterol regulatory element-binding protein pathway: Current insights. Molecular Endocrinology (Baltimore, Md.), 20(10), 2265&ndash;77. doi:10.1210/me.2005-0479</p>\n\n<p>Murashima, A., Kishigami, S., Thomson, A., &amp; Yamada, G. (2015). Androgens and mammalian male reproductive tract development. Biochimica et Biophysica Acta, 1849(2), 163&ndash;170. doi:10.1016/j.bbagrm.2014.05.020</p>\n\n<p>Paduch, D. A., Brannigan, R. E., Fuchs, E. F., Kim, E. D., Marmar, J. L., &amp; Sandlow, J. I. (2014). The laboratory diagnosis of testosterone deficiency. Urology, 83(5), 980&ndash;8. doi:10.1016/j.urology.2013.12.024</p>\n\n<p>Taieb, J., Mathian, B., Millot, F., Patricot, M.-C., Mathieu, E., Queyrel, N., &hellip; Boudou, P. (2003). Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clinical Chemistry, 49(8), 1381&ndash;95.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect7_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect7, dataSource, Effect_DownstreamEffect.class,2.0);
effect_downstreameffect7.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect7,dataSource,"(Key) Event Essentiality","", effect_downstreameffect7_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect9 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect9.setTitle("Reduction, Cholesterol transport in mitochondria");
effect_downstreameffect9.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "cellular");
effect_downstreameffect9.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Mus musculus, Homo sapiens, Rattus norvegicus");
effect_downstreameffect9.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect9.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect9,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><b>Biological state</b>\n\n</p><p>Steroidogenesis begins with the transport of cholesterol from intracellular stores into mitochondria. This process involves a series of protein-protein interactions involving cytosolic and mitochondrial proteins located at both the outer and inner mitochondrial membranes. In steroidogenic cells the cholesterol import to the mitochondrial inner membrane is crucial for steroid synthesis (Rone, Fan, and Papadopoulos 2009). This process is facilitated by the Scavenger Receptor Class B, type 1 (SR-B1) [more relevant for rodents, than for humans] that mediates the selective uptake of cholesterol esters from high-density lipoproteins. Steroidogenic acute regulatory protein (STAR) and the translator protein (TSPO) [former peripheral benzodiazepine receptor (PBR)]  mediate cholesterol transport from the outer to the inner mitochondrial membrane. The conversion of cholesterol to pregnenolone is done by Cholesterol side-chain cleavage enzyme (P450scc), the start of steroidogenesis [reviewed in (Miller and Auchus 2011)].\n\n</p><p><br />\n\n<b>Biological compartments</b>\n\n</p><p>In mitochondria of steroidogenic tissues there are two specialized mechanisms related to hormone synthesis: one by which cholesterol is delivered to the mitochondria and the other by which specialized intra-mitochondrial enzymes participate in the synthesis of hormonal steroids. \n\n</p><p><br />\n\n</p><p><b>General role in biology</b>\n\n</p><p>Systemic steroid hormones are primarily formed by the gonads, adrenal glands, and during in utero development by the placenta. Some other organs like brain (Baulieu 1998), and heart (Kayes-Wandover and White 2000) have also been identified as steroid-producing tissues, mainly for local needs. The steroid hormones are indispensable for mammalian life. They are made from cholesterol via complex biosynthetic pathways that are initiated by specialized, tissue-specific enzymes in mitochondria. These hormones include glucocorticoids (cortisol, corticosterone) and mineralocorticoids (aldosterone) produced in the adrenal cortex, estrogens (estradiol), progestins (progesterone) and androgens (testosterone, dihydrotestosterone) produced in the gonads, and calciferols (1,25-dihydroxy vitamin D [1,25OH2D]) produced in the kidneys (Miller and Auchus 2011). Cholesterol is the precursor for the synthesis of steroid hormones in mitochondria. Steroidogenesis begins with the metabolism of cholesterol to pregnenolone facilitated by P450scc. The rate of steroid formation depends on the rate of cholesterol transport from intracellular stores to the inner mitochondrial membrane and the loading of P450scc with cholesterol (Miller and Auchus 2011). \n\nInterference with one or more of these reactions leads to reduced steroid production.\n\n</p></p></div><div class='references'><h3>References</h3><p><p>Albalat, Ricard, Frédéric Brunet, Vincent Laudet, and Michael Schubert. 2011. “Evolution of Retinoid and Steroid Signaling: Vertebrate Diversification from an Amphioxus Perspective.” Genome Biology and Evolution 3: 985–1005. doi:10.1093/gbe/evr084.\n\n</p><p>Baulieu, E E. 1998. “Neurosteroids: A Novel Function of the Brain.” Psychoneuroendocrinology 23 (8) (November): 963–87.\n\n</p><p>Charman, Mark, Barry E Kennedy, Nolan Osborne, and Barbara Karten. 2010. “MLN64 Mediates Egress of Cholesterol from Endosomes to Mitochondria in the Absence of Functional Niemann-Pick Type C1 Protein.” Journal of Lipid Research 51 (5) (May): 1023–34. doi:10.1194/jlr.M002345.\n\n</p><p>Kayes-Wandover, K M, and P C White. 2000. “Steroidogenic Enzyme Gene Expression in the Human Heart.” The Journal of Clinical Endocrinology and Metabolism 85 (7) (July): 2519–25. doi:10.1210/jcem.85.7.6663.\n\n</p><p>Miller, Walter L, and Richard J Auchus. 2011. “The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders.” Endocrine Reviews 32 (1) (February): 81–151. doi:10.1210/er.2010-0013.\n\n</p><p>Rone, Malena B, Jinjiang Fan, and Vassilios Papadopoulos. 2009. “Cholesterol Transport in Steroid Biosynthesis: Role of Protein-Protein Interactions and Implications in Disease States.” Biochimica et Biophysica Acta 1791 (7) (July): 646–58. doi:10.1016/j.bbalip.2009.03.001.\n\n</p><p>Schroeder, F, J F Holland, and L L Bieber. 1971. “Fluorometric Evidence for the Binding of Cholesterol to the Filipin Complex.” The Journal of Antibiotics 24 (12) (December): 846–9.\n\n</p><p>Steer, C. 1984. “Detection of Membrane Cholesterol by Filipin in Isolated Rat Liver Coated Vesicles Is Dependent upon Removal of the Clathrin Coat.” The Journal of Cell Biology 99 (1) (July 1): 315–319. doi:10.1083/jcb.99.1.315.\n\n</p></p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect9_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect9, dataSource, Effect_DownstreamEffect.class,1.0);
effect_downstreameffect9.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect9,dataSource,"(Key) Event Essentiality","", effect_downstreameffect9_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect11 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect11.setTitle("Increase, Luteinizing hormone (LH) ");
effect_downstreameffect11.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "cellular");
effect_downstreameffect11.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Rattus norvegicus");
effect_downstreameffect11.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect11.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect11,dataSource,"Description","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect11_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect11, dataSource, Effect_DownstreamEffect.class,2.0);
effect_downstreameffect11.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect11,dataSource,"(Key) Event Essentiality","", effect_downstreameffect11_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

link_effecttoeffect5 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect3, effect_downstreameffect4);
link_effecttoeffect5.setLinkType(LinkType.DIRECT);link_effecttoeffect5.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect5,dataSource,"Description","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect5_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect5, dataSource, Link_EffectToEffect.class,2.0);
link_effecttoeffect5.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect5,dataSource,"(Key) Event Relationship Weight of Evidence","", link_effecttoeffect5_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect5.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect5,dataSource,"Evidence Supporting Taxonomic Applicability","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect5.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect5,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect8 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect6, effect_downstreameffect7);
link_effecttoeffect8.setLinkType(LinkType.DIRECT);link_effecttoeffect8.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect8,dataSource,"Description","<div class='description'><h3>Description</h3><p><p>Impairment of testosterone production in testes directly impacts on testosterone levels.</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Akingbemi, B. T. 2001. &ldquo;Modulation of Rat Leydig Cell Steroidogenic Function by Di(2-Ethylhexyl)Phthalate.&rdquo; Biology of Reproduction 65 (4) (October 1): 1252&ndash;1259. doi:10.1095/biolreprod65.4.1252.</p>\n\n<p>Borch, Julie, Ole Ladefoged, Ulla Hass, and Anne Marie Vinggaard. 2004. &ldquo;Steroidogenesis in Fetal Male Rats Is Reduced by DEHP and DINP, but Endocrine Effects of DEHP Are Not Modulated by DEHA in Fetal, Prepubertal and Adult Male Rats.&rdquo; Reproductive Toxicology (Elmsford, N.Y.) 18 (1): 53&ndash;61. doi:10.1016/j.reprotox.2003.10.011.</p>\n\n<p>Borch, Julie, Stine Broeng Metzdorff, Anne Marie Vinggaard, Leon Brokken, and Majken Dalgaard. 2006. &ldquo;Mechanisms Underlying the Anti-Androgenic Effects of Diethylhexyl Phthalate in Fetal Rat Testis.&rdquo; Toxicology 223 (1-2) (June 1): 144&ndash;55. doi:10.1016/j.tox.2006.03.015.</p>\n\n<p>Culty, Martine, Raphael Thuillier, Wenping Li, Yan Wang, Daniel B Martinez-Arguelles, Carolina Gesteira Benjamin, Kostantinos M Triantafilou, Barry R Zirkin, and Vassilios Papadopoulos. 2008. &ldquo;In Utero Exposure to Di-(2-Ethylhexyl) Phthalate Exerts Both Short-Term and Long-Lasting Suppressive Effects on Testosterone Production in the Rat.&rdquo; Biology of Reproduction 78 (6) (June): 1018&ndash;28. doi:10.1095/biolreprod.107.065649.</p>\n\n<p>Hannas, Bethany R, Christy S Lambright, Johnathan Furr, Nicola Evans, Paul M D Foster, Earl L Gray, and Vickie S Wilson. 2012. &ldquo;Genomic Biomarkers of Phthalate-Induced Male Reproductive Developmental Toxicity: A Targeted RT-PCR Array Approach for Defining Relative Potency.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 125 (2) (February): 544&ndash;57. doi:10.1093/toxsci/kfr315.</p>\n\n<p>Parks, L. G. 2000. &ldquo;The Plasticizer Diethylhexyl Phthalate Induces Malformations by Decreasing Fetal Testosterone Synthesis during Sexual Differentiation in the Male Rat.&rdquo; Toxicological Sciences 58 (2) (December 1): 339&ndash;349. doi:10.1093/toxsci/58.2.339.</p>\n\n<p>Shultz, V. D. 2001. &ldquo;Altered Gene Profiles in Fetal Rat Testes after in Utero Exposure to Di(n-Butyl) Phthalate.&rdquo; Toxicological Sciences 64 (2) (December 1): 233&ndash;242. doi:10.1093/toxsci/64.2.233.</p>\n\n<p>Wilson, Vickie S., Christy Lambright, Johnathan Furr, Joseph Ostby, Carmen Wood, Gary Held, and L.Earl Gray. 2004. &ldquo;Phthalate Ester-Induced Gubernacular Lesions Are Associated with Reduced insl3 Gene Expression in the Fetal Rat Testis.&rdquo; Toxicology Letters 146 (3) (February): 207&ndash;215. doi:10.1016/j.toxlet.2003.09.012.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect8_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect8, dataSource, Link_EffectToEffect.class,3.0);
link_effecttoeffect8.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect8,dataSource,"(Key) Event Relationship Weight of Evidence","<div class='biological-plausibility'><h3>Biological Plausibility</h3><p><p>Within the testes, steroid synthesis takes place within the mitochondria of Leydig cells. Testosterone production by Leydig cells is primarily under the control of LH. LH indirectly stimulates the transfer of cholesterol into the mitochondrial matrix to cholesterol side-chain cleavage cytochrome P450 (P450scc, CYP11A), which converts cholesterol to pregnenolone. Pregnenolone diffuses to the smooth endoplasmic reticulum where it is further metabolized to testosterone via the actions of 3&beta;-hydroxysteroid dehydrogenase &Delta;5-&Delta;4-isomerase (3&beta;-HSD), 17&alpha;-hydroxylase/C17-20 lyase (P450c17, CYP17), and 17&beta;-hydroxysteroid dehydrogenase type III (17HSD3). For review see (Payne &amp; Hales, 2013). Therefore, inhibition or impairment of the testosterone production directly impacts on the levels of testosterone.</p>\n\n</p></div><div class='empirical-support-for-linkage'><h3>Empirical Support for Linkage</h3><p><p>There is evidence from experimental work that demonstrates a coordinated, dose-dependent reduction in the production of testosterone and consecutive reduction of testosterone levels in foetal testes and in serum, see Table 1.</p>\n\n<table class=\"wikitable\" id=\"Event439\">\n\n	<tbody>\n\n		<tr>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p><strong>KE: testosterone synthesis, reduction</strong></p>\n\n			</td>\n\n			<td>\n\n			<p><strong>KE: testosterone, reduction</strong></p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Compound</p>\n\n			</td>\n\n			<td>\n\n			<p>Species</p>\n\n			</td>\n\n			<td>\n\n			<p>Effect level</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>Details</p>\n\n			</td>\n\n			<td>\n\n			<p>References</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL =300&nbsp;mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone production, reduction (ex vivo)</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone levels, reduction, no change plasma testosterone</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone levels at GD 21 in male rat fetuses exposed to 0, 10, 30, 100, or 300&nbsp;mg /kg bw/day from GD 7 to GD 21 testicular testosterone production ex vivo</p>\n\n			</td>\n\n			<td>\n\n			<p>(Borch, Metzdorff, Vinggaard, Brokken, &amp; Dalgaard, 2006)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL =50 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone levels, reduction,</p>\n\n			</td>\n\n			<td>\n\n			<p>Testicular testosterone was reduced &gt;50 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>(Shultz, 2001)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>fetal testicular testosterone production, reduction</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Borch, Ladefoged, Hass, &amp; Vinggaard, 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone levels, reduction,</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Borch et al., 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>No change plasma testosterone</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Borch et al., 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=100 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>Serum testosterone levels, reduction,</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Akingbemi, 2001)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg /kg /day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone levels, reduction, by 60 &ndash; 85%</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Parks, 2000)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg /kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone levels, reduction, fetuses on GD 17 (71% lower than controls) and 18 (47% lower than controls)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Parks, 2000)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750mg/kg/day</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>ex vivo testosterone production, reduction by 50%</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Wilson et al., 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=234 mg/kg/day</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>serum testosterone levels, reduction,</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Culty et al., 2008)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=1250 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p><em>ex vivo</em> foetal testicular production</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Culty et al., 2008)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>ED50=444,2 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p><em>ex vivo</em> foetal testicular production, reduction</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p><br />\n\n			(Hannas et al., 2012)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>ED50=75.25 mg/kg/day</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p><em>ex vivo</em> foetal testicular production, reduction</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Hannas et al., 2012)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n	</tbody>\n\n</table>\n\n<p>Table 1. Summary table for empirical support for this KER. ED50 - half maximal effective concentration, LOEL- lowest observed effect level, Dibutyl phthalate (DBP), Bis(2-ethylhexyl) phthalate (DEHP), Dihexyl Phthalate (DHP).</p>\n\n</p></div>", link_effecttoeffect8_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect8.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect8,dataSource,"Evidence Supporting Taxonomic Applicability","<p>Ses Table 1.</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect8.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect8,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect10 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect9, effect_downstreameffect6);
link_effecttoeffect10.setLinkType(LinkType.DIRECT);link_effecttoeffect10.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect10,dataSource,"Description","<div class='description'><h3>Description</h3><p><p>Production of steroid hormones depends on the availability of cholesterol in the mitochondrial matrix. A decreased amount of cholesterol inside the mitochondria (e. g by decreased expression of enzymes that transport cholesterol like StAR or TSOP) means diminished substrate for hormone (testosterone) production in testes.</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Barlow, N. J., Phillips, S. L., Wallace, D. G., Sar, M., Gaido, K. W., &amp; Foster, P. M. D. (2003). Quantitative changes in gene expression in fetal rat testes following exposure to di(n-butyl) phthalate. Toxicological Sciences : An Official Journal of the Society of Toxicology, 73(2), 431&ndash;41. doi:10.1093/toxsci/kfg087</p>\n\n<p>Boberg, J., Metzdorff, S., Wortziger, R., Axelstad, M., Brokken, L., Vinggaard, A. M., &hellip; Nellemann, C. (2008). Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology, 250(2-3), 75&ndash;81. doi:10.1016/j.tox.2008.05.020</p>\n\n<p>Borch, J., Ladefoged, O., Hass, U., &amp; Vinggaard, A. M. (2004). Steroidogenesis in fetal male rats is reduced by DEHP and DINP, but endocrine effects of DEHP are not modulated by DEHA in fetal, prepubertal and adult male rats. Reproductive Toxicology (Elmsford, N.Y.), 18(1), 53&ndash;61. doi:10.1016/j.reprotox.2003.10.011</p>\n\n<p>Borch, J., Metzdorff, S. B., Vinggaard, A. M., Brokken, L., &amp; Dalgaard, M. (2006). Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology, 223(1-2), 144&ndash;55. doi:10.1016/j.tox.2006.03.015</p>\n\n<p>Chauvign&eacute;, F., Plummer, S., Lesn&eacute;, L., Cravedi, J.-P., Dejucq-Rainsford, N., Fostier, A., &amp; J&eacute;gou, B. (2011). Mono-(2-ethylhexyl) phthalate directly alters the expression of Leydig cell genes and CYP17 lyase activity in cultured rat fetal testis. PloS One, 6(11), e27172. doi:10.1371/journal.pone.0027172</p>\n\n<p>Furr, J. R., Lambright, C. S., Wilson, V. S., Foster, P. M., &amp; Gray, L. E. (2014). A short-term in vivo screen using fetal testosterone production, a key event in the phthalate adverse outcome pathway, to predict disruption of sexual differentiation. Toxicological Sciences : An Official Journal of the Society of Toxicology, 140(2), 403&ndash;24. doi:10.1093/toxsci/kfu081</p>\n\n<p>Gazouli, M. (2002). Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor . Endocrinology, 143(7), 2571&ndash;2583. doi:10.1210/en.143.7.2571</p>\n\n<p>Hauet, T., Yao, Z.-X., Bose, H. S., Wall, C. T., Han, Z., Li, W., &hellip; Papadopoulos, V. (2005). Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Molecular Endocrinology (Baltimore, Md.), 19(2), 540&ndash;54. doi:10.1210/me.2004-0307</p>\n\n<p>Johnson, K. J., McDowell, E. N., Viereck, M. P., &amp; Xia, J. Q. (2011). Species-specific dibutyl phthalate fetal testis endocrine disruption correlates with inhibition of SREBP2-dependent gene expression pathways. Toxicological Sciences : An Official Journal of the Society of Toxicology, 120(2), 460&ndash;74. doi:10.1093/toxsci/kfr020</p>\n\n<p>Lehmann, K. P., Phillips, S., Sar, M., Foster, P. M. D., &amp; Gaido, K. W. (2004). Dose-dependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate. Toxicological Sciences : An Official Journal of the Society of Toxicology, 81(1), 60&ndash;8. doi:10.1093/toxsci/kfh169</p>\n\n<p>Li, Y., Ramdhan, D. H., Naito, H., Yamagishi, N., Ito, Y., Hayashi, Y., &hellip; Nakajima, T. (2011). Ammonium perfluorooctanoate may cause testosterone reduction by adversely affecting testis in relation to PPAR&alpha;. Toxicology Letters, 205(3), 265&ndash;72. doi:10.1016/j.toxlet.2011.06.015 Miller, W. L. (2007). Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochimica et Biophysica Acta, 1771(6), 663&ndash;76. doi:10.1016/j.bbalip.2007.02.012</p>\n\n<p>Parks, L. G. (2000). The Plasticizer Diethylhexyl Phthalate Induces Malformations by Decreasing Fetal Testosterone Synthesis during Sexual Differentiation in the Male Rat. Toxicological Sciences, 58(2), 339&ndash;349. doi:10.1093/toxsci/58.2.339</p>\n\n<p>Payne, A. H., &amp; Hales, D. B. (2013). Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones. Endocrine Reviews. Stocco, D. M. (2001). StAR protein and the regulation of steroid hormone biosynthesis. Annual Review of Physiology, 63, 193&ndash;213. doi:10.1146/annurev.physiol.63.1.193</p>\n\n<p>Svechnikov, K., Svechnikova, I., &amp; S&ouml;der, O. (2008). Inhibitory effects of mono-ethylhexyl phthalate on steroidogenesis in immature and adult rat Leydig cells in vitro. Reproductive Toxicology (Elmsford, N.Y.), 25(4), 485&ndash;90. doi:10.1016/j.reprotox.2008.05.057</p>\n\n<p>Thompson, C. J., Ross, S. M., &amp; Gaido, K. W. (2004). Di(n-butyl) phthalate impairs cholesterol transport and steroidogenesis in the fetal rat testis through a rapid and reversible mechanism. Endocrinology, 145(3), 1227&ndash;37. doi:10.1210/en.2003-1475</p>\n\n<p>Thompson, C. J., Ross, S. M., Hensley, J., Liu, K., Heinze, S. C., Young, S. S., &amp; Gaido, K. W. (2005). Differential steroidogenic gene expression in the fetal adrenal gland versus the testis and rapid and dynamic response of the fetal testis to di(n-butyl) phthalate. Biology of Reproduction, 73(5), 908&ndash;17. doi:10.1095/biolreprod.105.042382</p>\n\n<p>Wilson, V. S., Lambright, C., Furr, J., Ostby, J., Wood, C., Held, G., &amp; Gray, L. E. (2004). Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicology Letters, 146(3), 207&ndash;15.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect10_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect10, dataSource, Link_EffectToEffect.class,2.0);
link_effecttoeffect10.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect10,dataSource,"(Key) Event Relationship Weight of Evidence","<div class='biological-plausibility'><h3>Biological Plausibility</h3><p><p>Steroid hormones play a critical role in sexual development, homeostasis, stress-responses, carbohydrate metabolism, tumor growth, and reproduction. These hormones are primarily produced in specialized steroidogenic tissues and are synthesized from a common precursor, cholesterol. Mitochondria are a key control point for the regulation of steroid hormone biosynthesis. The first and rate-limiting step in steroidogenesis is the transfer of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane, a process dependent on the action of StAR (Stocco, 2001) and the subsequent transport across the inner mitochondrial space into the steroidogenic pathway, which is executed by TSPO (Hauet et al., 2005). Testosterone production by Leydig cells is primarily under the control of luteinizing hormone (LH). Stimulation of the Leydig cells results in the activation of StAR transcription and translation, which facilitates the transfer of cholesterol into the mitochondrial matrix to cholesterol side-chain cleavage cytochrome P450 (P450scc, CYP11A), which converts cholesterol to pregnenolone. Pregnenolone diffuses to the smooth endoplasmic reticulum where it is further metabolized to testosterone via the actions of 3&beta;-hydroxysteroid dehydrogenase &Delta;5-&Delta;4-isomerase (3&beta;-HSD), 17&alpha;-hydroxylase/C17-20 lyase (P450c17, CYP17), and 17&beta;-hydroxysteroid dehydrogenase type III (17HSD3). For review see (Payne &amp; Hales, 2013). Decreased expression of genes that are responsible for cholesterol transport and steroidogenic enzyme activities in the Leydig cell leads to decreased testosterone production.</p>\n\n</p></div><div class='empirical-support-for-linkage'><h3>Empirical Support for Linkage</h3><p><p>There is evidence from experimental work that demonstrates a coordinated reduction in the expression of key genes and proteins that are involved in cholesterol transport and steroidogenesis, together with a corresponding reduction in testosterone in testes. For details see Table 1. Foetal Leydig cells exhibit a high rate of lipid metabolism, which is required for both synthesizing and importing the testosterone precursor cholesterol. Upon exposure to some chemicals mRNA expression of genes in these pathways are profoundly reduced e.g. following 500mg/kg phthalate (DBP) exposure (Johnson, McDowell, Viereck, &amp; Xia, 2011), (Thompson et al., 2005). Additionally, after phthalate exposure testis cholesterol and cholesterol-containing lipid droplets in foetal Leydig cells are also reduced (Barlow et al., 2003), (Johnson et al., 2011), (Lehmann, Phillips, Sar, Foster, &amp; Gaido, 2004).</p>\n\n<p>&nbsp;</p>\n\n<table class=\"wikitable\" id=\"Event438\">\n\n	<tbody>\n\n		<tr>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p><strong>KE: Cholesterol transport, reduction</strong></p>\n\n			</td>\n\n			<td>\n\n			<p><strong>KE: Testosterone production/levels, reduction</strong></p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Compound</p>\n\n			</td>\n\n			<td>\n\n			<p>Species</p>\n\n			</td>\n\n			<td>\n\n			<p>Effect level</p>\n\n			</td>\n\n			<td>\n\n			<p>Translator protein (TSPO), decrease; Steroidogenic acute regulatory protein (StAR) decrease</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>mRNA StAR decrease (by ~34%)(Barlow et al., 2003)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (BBP, DPeP, DEHP, DHP, DiHeP, DCHP, DINP DHeP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP, DEHP, BBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>Rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg/kg/day (GD14-18)</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>testosterone production, reduction ex vivo fetal testes examined on GD18 (Wilson et al., 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>reduced Leydig cell lipid content(Barlow et al., 2003)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day GD 12 -20, examinations on GD20</p>\n\n			</td>\n\n			<td>\n\n			<p>total cholesterol levels, reduction</p>\n\n			</td>\n\n			<td>\n\n			<p>intratesticular testosterone levels, reduction (by nearly 90%)(Johnson et al., 2011)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day (GD12-19)</p>\n\n			</td>\n\n			<td>\n\n			<p>decrease uptake of cholesterol Leydig cell mitochondria gd 19</p>\n\n			</td>\n\n			<td>\n\n			<pre>\n\ntestosterone production, reduction ex vivo (Thompson, Ross, &amp; Gaido, 2004)\n\n</pre>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=1 g/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>reduced TSPO mRNA</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone levels, reduction (Gazouli, 2002)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300&nbsp;mg/ kg/day</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>dose-dependently reduced StAR, TSOP mRNA (GD 21 testes), also on protein levels in Leydig cells (Borch, Metzdorff, Vinggaard, Brokken, &amp; Dalgaard, 2006)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300&nbsp;mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone production, reduction (ex vivo) testosterone levels, reduction (Borch et al., 2006), (Borch, Ladefoged, Hass, &amp; Vinggaard, 2004)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<ul>\n\n				<li>\n\n				<p>reduced TSPO mRNA levels by 50%,</p>\n\n				</li>\n\n				<li>\n\n				<p>binding sites decreased by 50%</p>\n\n				</li>\n\n				<li>\n\n				<p>no effect on receptor affinity</p>\n\n				</li>\n\n				<li>\n\n				<p>inhibited the transfer or loading of cholesterol to the inner mitochondrial membrane P450scc. (Gazouli, 2002)</p>\n\n				</li>\n\n			</ul>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>IC50 =100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<ul>\n\n				<li>\n\n				<p>inhibited formation of progesterone (Gazouli, 2002)</p>\n\n				</li>\n\n			</ul>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=250&nbsp;&mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>cholesterol transport, decrease (into the mitochondria of immature and adult Leydig cells)</p>\n\n			</td>\n\n			<td>\n\n			<p>Testosterone, reduction by approximately 60%, in vitro ( immature and adult Leydig cells) (Svechnikov, Svechnikova, &amp; S&ouml;der, 2008)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone production reduction, testosterone levels, reduction (testicular and whole-body T levels in fetal and neonatal male rats from GD 17 to PND 2. (Parks, 2000)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=1 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone production, reduction dose-dependent (Chauvign&eacute; et al., 2011)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Perfluorooctanoic acid (PFOA)</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=5mg/kg/day</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>plasma testosterone, reduction (by 37%)(Li et al., 2011)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>WY-14,643</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=50 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>reduced TSPO mRNA</p>\n\n			</td>\n\n			<td>\n\n			<p>Serum testosterone levels, reduction (Gazouli, 2002)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>WY-14,643</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>No decrease of testosterone ( ex vivo), (Furr, Lambright, Wilson, Foster, &amp; Gray, 2014)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>WY-14,643</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>Inhibited progesterone synthesis (Gazouli, 2002)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Bezafibrate</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>IC50=100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<ul>\n\n				<li>\n\n				<p>a dose-dependent 10&ndash;95% inhibition of the progesterone synthesis at 24 or 72 h</p>\n\n				</li>\n\n				<li>\n\n				<p>inhibited the transfer or loading of cholesterol to the inner mitochondrial membrane P450scc. At 100 &mu;M</p>\n\n				</li>\n\n				<li>\n\n				<p>binding sites of TSPO decreased IC50 of approximately 100 &mu;M</p>\n\n				</li>\n\n				<li>\n\n				<p>decrease TSPO levels by 60% at 100 &mu;M (Gazouli, 2002)</p>\n\n				</li>\n\n			</ul>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Bezafibrate</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>IC50 = 30 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>inhibited formation of progesterone (Gazouli, 2002)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Bezafibrate</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>IC50 ~10&minus;4 &mu;M</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>testosterone production, reduction (Gazouli, 2002)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DiBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>GD 19 -21</p>\n\n			</td>\n\n			<td>\n\n			<p>reduced StAR, (Boberg et al., 2008)</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone production and testicular testosterone levels, (Boberg et al., 2008)</p>\n\n			</td>\n\n		</tr>\n\n	</tbody>\n\n</table>\n\n<p><br />\n\nTable 1. Summary table of empirical support for this KER. IC50 half maximal inhibitory concentration, LOEC-lowest effect concentration, LOEL- lowest observed effect level, Dibutyl phthalate (DBP), diisobutyl phthalate (DiBP), Bis(2-ethylhexyl) phthalate (DEHP), Dibutyl phthalate (DBP), Bezafibrate and WY-14,643 are PPAR&alpha; ligands, n.a - not available</p>\n\n</p></div><div class='uncertainties-or-inconsistencies'><h3>Uncertainties or Inconsistencies</h3><p><p>Thompson et al investigated time course effects of phthalate on steroidogenesis gene expression and testosterone concentration. The study showed diminished concentration testosterone concentration in the foetal testis by 50% within 1h of treatment with phthalate (DBP). Surprisingly, the diminution in testosterone concentration preceded any alteration in expression of genes in the steroidogenesis pathway. Star mRNA was significantly diminished 2 h after DBP exposure, but Cyp11a1, Cyp17a1, and Scarb1 did not show a significant decrease in expression until 6 h after DBP exposure (Thompson et al., 2005). In utero exposure of rats to PFOA 20 mg/kg did not cause any effect on fetal testosterone (Boberg et.al. 2008) although in mice (adult) the decrease level of testosterone was observed. Testosterone production may also be diminished due to reduction/inhibition of other genes involved in steroidogenesis (e.g. P450scc, Cyp17a1) (Thompson et al., 2004), (Boberg et al., 2008), (Chauvign&eacute; et al., 2009), (Chauvign&eacute; et al., 2011).</p>\n\n</p></div>", link_effecttoeffect10_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect10.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect10,dataSource,"Evidence Supporting Taxonomic Applicability","<p>See Table 1.</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect10.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect10,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect12 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect7, effect_downstreameffect11);
link_effecttoeffect12.setLinkType(LinkType.INDIRECT);link_effecttoeffect12.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect12,dataSource,"Description","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect12_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect12, dataSource, Link_EffectToEffect.class,2.0);
link_effecttoeffect12.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect12,dataSource,"(Key) Event Relationship Weight of Evidence","", link_effecttoeffect12_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect12.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect12,dataSource,"Evidence Supporting Taxonomic Applicability","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect12.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect12,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect13 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect11, effect_downstreameffect3);
link_effecttoeffect13.setLinkType(LinkType.INDIRECT);link_effecttoeffect13.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect13,dataSource,"Description","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect13_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect13, dataSource, Link_EffectToEffect.class,2.0);
link_effecttoeffect13.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect13,dataSource,"(Key) Event Relationship Weight of Evidence","", link_effecttoeffect13_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect13.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect13,dataSource,"Evidence Supporting Taxonomic Applicability","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect13.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect13,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect14 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect4, effect_adverseoutcome2);
link_effecttoeffect14.setLinkType(LinkType.INDIRECT);link_effecttoeffect14.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect14,dataSource,"Description","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect14_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect14, dataSource, Link_EffectToEffect.class,2.0);
link_effecttoeffect14.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect14,dataSource,"(Key) Event Relationship Weight of Evidence","", link_effecttoeffect14_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect14.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect14,dataSource,"Evidence Supporting Taxonomic Applicability","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect14.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect14,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

pathway.getGroups().parseString("");
pathway.getUids().parseString("SHORTNAME:PPAR and reproductive toxicity,");
pathway.getStatus().parseString("OECD:Under Development,SAAOP:Included in OECD Work Plan,AOPWIKI:Under development: Not open for comment. Do not cite,");

pathway.updateEssentiality();
EssetialityDescription essentiality = pathway.getEssentiality();
DescriptionSection_Structured dss;
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Abstract","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Background","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 1);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Essentiality Support","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Quantitative Considerations","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Applicability of the AOP","<ul><li><strong>Sexes</strong>:Male</li><li><strong>Life Stages</strong>:Adult, reproductively mature, Juvenile</li><li><strong>Taxonomies</strong>:Rattus norvegicus</li></ul>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 4);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Potential Applications of the AOP","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 5);
dss = essentiality.getEssentialityDescription(effect_molecularinitiatingevent1);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(1.0);
dss = essentiality.getEssentialityDescription(effect_adverseoutcome2);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(0.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect3);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(2.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect4);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(2.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect6);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(2.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect7);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(2.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect9);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(1.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect11);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(2.0);
}
}
